Latest articles & news
HelicoBio is looking to generate compounds for drug development through turning plants into factories.
Helico is aiming to produce therapeutic compounds from plantsand, ultimately, ‘edible medicine’, with insulin its first target.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas in New Zealand that international investors say they’re either actively investing in or watching for signs of scale.
Helico is designing plants to manufacture life-saving medicines.